百普力用于老年危重症患者肠内营养疗效观察  

Effect of Peptisorb on Enteral Nutrition in Critical Elderly Patients

作　　者：吕心阳[1] Lv Xinyang(Department of Clinic Cadre, the Provincial Hospital of Fujian, Fuzhou 350001, China)

机构地区：[1]福建省立医院干部特诊一科,中国福州350001

出　　处：《国际老年医学杂志》2016年第6期279-281,共3页International Journal of Geriatrics

摘　　要：目的：比较能全力和百普力肠内营养的临床疗效及并发症发生情况,探讨百普力的有效性及安全性.方法：48例患者随机分为百普力组（28例）和能全力组（20例）,分别给予百普力和能全力进行肠内营养治疗,比较营养学指标（白蛋白、转铁蛋白、前白蛋白）,免疫指标（淋巴细胞总数）以及不良反应发生情况（吸入性肺炎、腹泻、便秘、肝功能异常）.结果：两组免疫学指标及便秘、肝功能异常等不良反应的发生率差异无统计学意义,百普力组营养学指标改善,肺炎、腹泻的发生率更低（P＜0.05）.结论：百普力应用于老年危重症患者,特别是具有胃肠道功能障碍的老年患者,具有良好的有效性及安全性.OBJECTIVE ： To discuss the effect and safety of peptisorb on entral nutrition in critical elderly patients. METHODS ： 48 patients were randomly divided into Peptisorb group （n = 28 ） and Nutrison Fibre group （n = 20 ）. Peptisorb and Nutrison Fibre were used respectively for enteral nutrition therapy. These patients＇ nutrition indicators （albumin, transferrin and prealbemin） , im- mune indicators （total lymphocyte count） and side effects （aspiration pneumonia, diarrhea, constipation and abnormal liver func- tion） were compared. RESULTS： There was no statistically significante difference in the immune indicators and side effests. The oc- currence rate of pneumonia was decreased in Peptisorb group （ P 〈 0. 05 ）. Peptisorb had satisfactory effectiveness and safety in enteral nutrition therapy. CONCLUSION： Peptisorb could be used in the critical elderly patients, especially those patients with gastrointestinal functional disorder.

关 键 词：百普力 能全力 肠内营养 有效性 安全性 

分 类 号：R735.1[医药卫生—肿瘤]